Lunsumio

mosunetuzumab-axgb

Approval

ApplicationBLA 761263
Approval dateDec 22, 2022
Approval year2022
SponsorGenentech INC

FDA-approved use

To treat adults with relapsed or refractory follicular lymphoma, a type of non-Hodgkin lymphoma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Lunsumio: